Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Alopecia areata involves immune response and gene changes affecting hair loss.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Trichoscopy is a reliable method for diagnosing hair and scalp disorders quickly and non-invasively.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

H19 boosts hair growth potential by activating Wnt signaling, possibly helping treat hair loss.

Extraction videodermoscopy is an effective, non-invasive diagnostic tool for eruptive vellus hair cysts.

Diagnosing thyroid disorders is complex and requires thorough testing due to nonspecific symptoms like hair loss.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Inverted Follicular Keratosis is rare but should be considered in scalp lesion diagnoses for all ages.

Skin symptoms like fragile skin and easy bruising can indicate Cushing's syndrome, which requires early diagnosis and treatment to prevent serious health issues.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

A man developed skin issues from cancer medication, which improved with specific treatments.

Low iron levels may be linked to some types of hair loss in women.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

The cause of the syndrome with scalp scaling and hair loss is unknown.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.